Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

This randomized controlled clinical trial evaluates neurocognitive, biopsychological, and brain connectome outcomes in children and adolescents with acute lymphoblastic leukemia who have previously received Chimeric Antigen Receptor T-cell therapy (CAR T-cell therapy), chemotherapy, and/or hematopoietic stem cell transplantation (HSCT). Participants will receive a multimodal, telematic psychological intervention combining digital cognitive training and an adapted mindfulness-based emotional regulation program. Outcomes will be compared with a waitlist control group and intervention sequences

Trial Details

NCT ID
NCT07479927
Phase
NA
Sponsor
Hospital Universitario La Paz
Status
RECRUITING
Cancer Type
Leukemia
Interventions
  • Digital cognitive training
  • Online Mindfulness-Based Intervention
Locations (sample)
  • Madrid, Madrid, Spain|40.4165,-3.70256

Key Eligibility Criteria

  • Diagnosis of acute B-cell lymphoblastic leukemia.
  • Previous treatment with CAR-T therapy, chemotherapy, and/or hematopoietic stem cell transplantation.
  • Age between 8 and 18 years.
  • Native Spanish speaker or high proficiency in Spanish sufficient to understand study procedures and complete assessment instruments.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Leukemia Trials on Trialify →